Drug Deal Is Bet Price Pressures Have Eased

Takeda Pharmaceutical’s proposed acquisition of Ariad Pharmaceuticals for about $4.7 billion could boost valuations as buyers regain confidence in ability to raise prices.

from WSJ.com: Markets http://ift.tt/2iaRATu
via https://ifttt.com/ IFTTT